© 2026 Senseonics, Incorporated. All rights reserved.

20451 Seneca Meadows Parkway
Germantown, MD 20876-7005 USA
844-SENSE4U (736-7348)
eversensecgm.com

Eversense, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Other brands and their products are trademarks or registered trademarks of their respective holders and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a healthcare provider. The Eversense 365 CGM System is a prescription device; patients should talk to their healthcare provider to learn more. For safety information, see bit.ly/eversensesafety